The impact of COVID-19 on autism research: A cross-sectional analysis of discontinued or suspended clinical trials

Keyphrases

• Clinical Trials 100%
• Sectional Analysis 100%
• COVID-19 Impact 100%
• Autism Research 100%
• Autism 60%
• Discontinuation Rate 40%
• Reasons for Discontinuation 40%
• COVID-19 40%
• Medical Research 20%
• Pharmacological Studies 20%
• Drug Trials 20%
• Funding Sources 20%
• Autism Spectrum Disorder 20%
• Implications for Future 20%
• Non-pharmacological 20%
• Public Health Emergency 20%
• COVID-19 Pandemic Impact 20%
• Nutritional Trial 20%
• Behavioral Trial 20%
• Lay Summary 20%
• Diagnostic Trials 20%
• Pharmacological Assays 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Cross Sectional Study 100%
• Autism 20%
• Drug Screening 20%

Neuroscience

• Pervasive Developmental Disorder 100%